<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28555135</article-id><article-id pub-id-type="pmc">5431153</article-id><article-id pub-id-type="doi">10.3389/fimmu.2017.00544</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Why the Immune System Should Be Concerned by Nanomaterials?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pallardy</surname><given-names>Marc J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/384351"/></contrib><contrib contrib-type="author"><name><surname>Turbica</surname><given-names>Isabelle</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/436442"/></contrib><contrib contrib-type="author"><name><surname>Biola-Vidamment</surname><given-names>Armelle</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/436455"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>&#x0201c;Inflammation, Chimiokines and Immunopathology&#x0201d;, INSERM UMR 996, Univ Paris-Sud, Universit&#x000e9; Paris-Saclay</institution>, <addr-line>Ch&#x000e2;tenay-Malabry</addr-line>, <country>France</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Diana Boraschi, Consiglio Nazionale Delle Ricerche (CNR), Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Francesca Granucci, University of Milano-Bicocca, Italy; Giamila Fantuzzi, University of Illinois at Chicago, USA</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Marc J. Pallardy, <email>marc.pallardy@u-psud.fr</email></corresp><fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>15</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>544</elocation-id><history><date date-type="received"><day>29</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>24</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Pallardy, Turbica and Biola-Vidamment.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Pallardy, Turbica and Biola-Vidamment</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Particles possess huge specific surface area and therefore nanomaterials exhibit unique characteristics, such as special physical properties and chemical hyper-reactivity, which make them particularly attractive but also raise numerous questions concerning their safety. Interactions of nanomaterials with the immune system can potentially lead to immunosuppression, hypersensitivity (allergy), immunogenicity and autoimmunity, involving both innate and adaptive immune responses. Inherent physical and chemical NP characteristics may influence their immunotoxicity, i.e., the adverse effects that can result from exposure. This review will focus on the possible interaction of nanomaterials including protein aggregates with the innate immune system with specific emphasis on antigen-presenting cells, i.e., dendritic cells, macrophages and monocytes.</p></abstract><kwd-group><kwd>nanoparticles</kwd><kwd>dendritic cells</kwd><kwd>danger signals</kwd><kwd>macrophages</kwd><kwd>innate immunity</kwd></kwd-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="62"/><page-count count="6"/><word-count count="5211"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Nanoparticles (NP) are defined as structures with at least one dimension in the range of 1&#x02013;100&#x02009;nm. At this nanoscale, particles possess huge specific surface area. Nanomaterials therefore exhibit unique characteristics, such as special physical properties and chemical hyper-reactivity, which make them particularly attractive but also raise numerous questions concerning their safety. Nanomaterial interactions with the body include accidental exposure (environmental and industrial NP) and therapeutic exposure (vaccination, drug delivery). Virtually, all the possible routes of exposure (inhalation, ingestion, dermal contact, systemic injection) have to be considered.</p><p>The main objective of the immune system is to avoid harmful effects due to contamination by microbes and also to maintain an immune tolerance to environmental antigens. To distinguish between harmful and non-harmful antigens, the dendritic cells (DCs) play a major role by sensing the environment and adapting their phenotype to the most appropriate type of response: immunogenic vs. tolerogenic. Interactions of NP with the immune system can potentially lead to immunosuppression, hypersensitivity (allergy), immunogenicity and autoimmunity, involving both innate and adaptive immune responses. Inherent physical and chemical NP characteristics may influence their immunotoxicity, i.e., the adverse effects that can result from exposure. This review will focus on the possible interaction of nanomaterials, including protein aggregates, with the innate immune system with specific emphasis on antigen-presenting cells, i.e., DCs, macrophages and monocytes.</p></sec><sec id="S2"><title>NP Interaction with Innate Immune Cells</title><p>In host, the mononuclear phagocytic system plays a major role in the exposure to nanomaterials. Macrophages are in charge of nanomaterials recognition, uptake, processing, and clearance (<xref rid="B1" ref-type="bibr">1</xref>). Several <italic>in vivo</italic> studies have demonstrated high NPs macrophage sequestration, particularly in clearance organs such as liver, spleen, and kidney. In these organs, fenestrated capillary beds, competent to capture particles, are associated with specialized macrophages populations (<xref rid="B1" ref-type="bibr">1</xref>). In mice injected with non-degradable silica NPs, a high accumulation in the liver and in the spleen was observed, in majority in the macrophages but also in neutrophils (<xref rid="B2" ref-type="bibr">2</xref>). This property could be responsible for organ-specific toxicity, especially in the liver, of some NPs.</p><p>Nanoparticles uptake can occur through phagocytosis, macropinocytosis, as well as clathrin-, caveolae-, and scavenger receptor-mediated endocytic pathways. These internalization processes are deeply dependent on nanomaterials properties such as size, shape, surface coating, and on the cellular environment (<xref rid="B3" ref-type="bibr">3</xref>). Phagocytosis is carried out by professional phagocytes such as macrophages, neutrophils, DCs, or monocytes. Due to their actin-based cytoskeleton rearrangement capacities, these cells can entrap the material through membrane dynamics in a zipper model fashion (<xref rid="B1" ref-type="bibr">1</xref>). The best characterized opsonin-dependent phagocytosis receptors are the Fc&#x003b3; receptor and the complement receptor CR3, which appear to play a significant role in the detection of opsonized nanomaterials and in the rate of uptake (<xref rid="B1" ref-type="bibr">1</xref>). It was demonstrated that the small gold colloid NPs (30&#x02009;nm) use several internalization routes (including scavenger receptor-, clathrin-, and caveolin-mediated pathways), in contrast to the larger materials of 150&#x02009;nm which appear to be preferentially taken up via the scavenger receptor pathway (<xref rid="B4" ref-type="bibr">4</xref>). The scavenger receptor MARCO has been involved in the ingestion of unopsonized inhaled TiO<sub>2</sub> and Fe<sub>2</sub>O<sub>3</sub> particles in the lung (<xref rid="B5" ref-type="bibr">5</xref>). Moreover, the recognition of silica NPs by macrophages scavenger A receptor could induce the release of cytokines responsible for pulmonary inflammation (<xref rid="B6" ref-type="bibr">6</xref>). The mechanisms for NP uptake by DCs are poorly understood. However, according to Vallhov et al. (<xref rid="B7" ref-type="bibr">7</xref>), an active mechanism such as endocytosis may be involved in the amorphous silica nanoparticle (aSNP) uptake by DCs (<xref rid="B7" ref-type="bibr">7</xref>). Winter et al. (<xref rid="B8" ref-type="bibr">8</xref>) additionally suggested that it would be at least partly mediated by an actin-dependent mechanism (<xref rid="B8" ref-type="bibr">8</xref>).</p><p>Nanomaterials can affect the polarization and the reprogramming of macrophages, mostly depending on chemical composition, size, and surface modification (<xref rid="B9" ref-type="bibr">9</xref>). The pro-inflammatory M1 or anti-inflammatory M2 phenotypes have been shown to display distinct uptake capacity for nanomaterials. In particular, silica NPs uptake is enhanced in M2-polarized primary human monocyte-derived macrophages or in the macrophage-like THP-1 cell line as compared with M1 cells (<xref rid="B10" ref-type="bibr">10</xref>).</p><p><italic>In vivo</italic>, upon exposure to biological fluids, NPs do not stay &#x0201c;naked&#x0201d; but become coated by biomolecules, primarily proteins but also sugars, lipids, or nucleic acids, forming a &#x0201c;corona&#x0201d; (<xref rid="B11" ref-type="bibr">11</xref>). This corona is &#x0201c;what the cell sees&#x0201d; and displays a highly dynamic nature: changes in the composition occur over time, in a continuous flux of desorption/adsorption of proteins. If the &#x0201c;hard&#x0201d; corona is tightly bound with a long exchange time, the &#x0201c;soft&#x0201d; corona, presented as a second layer, is submitted to fast exchanges (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>). Interestingly, this process could be compared to the opsonization of pathogens (<xref rid="B14" ref-type="bibr">14</xref>) and affects the efficiency of NPs uptake by macrophages. Kapralov et al. demonstrated that single-walled carbon nanotubes (SWCNTs) selectively adsorbed phosphatidylcholines and phosphatidylglycerols from lung surfactant. The presence of this coating noticeably enhanced the <italic>in vitro</italic> uptake of SWCNTs by macrophages (<xref rid="B15" ref-type="bibr">15</xref>). Moreover, proteins may undergo conformational changes, such as unfolding, leading to the possible exposition of cryptic epitopes recognized by immune cells (<xref rid="B14" ref-type="bibr">14</xref>). This unfolding was demonstrated with fibrinogen coated on negatively charged poly(acrylic acid) gold NPs, leading to MAC-1 receptor activation and pro-inflammatory cytokines secretion through NF-&#x003ba;B signaling (<xref rid="B16" ref-type="bibr">16</xref>). Interestingly, only the negatively charged NPs induced TNF-&#x003b1; and IL-8 release by THP-1 cells, whereas both positively and negatively charged particles could bind fibrinogen with high affinity (<xref rid="B17" ref-type="bibr">17</xref>). This protein corona is essential for scavenger receptor-efficient internalization of synthetic-layered silicate NPs by THP-1 cells (<xref rid="B18" ref-type="bibr">18</xref>). When bound to these NPs, albumin undergoes unfolding, comparable to heat denaturation, revealing a cryptic sequence allowing recognition of serum albumin by this family of receptors and nanomaterial recognition by macrophages (<xref rid="B18" ref-type="bibr">18</xref>).</p></sec><sec id="S3"><title>DCs and Nanomaterials as Exogenous Danger Signals</title><p>Dendritic cells are professional antigen-presenting cells that bridge the innate and adaptive immune response. Immature DCs reside in non-lymphoid tissues in an antigen-capturing state. In the presence of various stimuli, such as allergens, inflammation, pro-inflammatory cytokines, bacterial products, or diverse danger signals, DCs undergo a maturation process. This process results in antigen-processing and upregulation of major histocompatibility complex (MHC), co-stimulatory molecules, chemokine, and cytokine receptors, and production of cytokines and chemokines. Mature DCs then migrate to regional lymph nodes and activate na&#x000ef;ve T-lymphocytes. Consequently, NP impact on these cells raises growing concerns.</p><p>The size of the NP may determine the modulation of DC functions. For example, <italic>in vivo</italic>, 20&#x02009;nm polystyrene (PS) particles are more frequently captured by lung DCs than 1,000&#x02009;nm PS particles (<xref rid="B19" ref-type="bibr">19</xref>). If the 20&#x02009;nm PS particle <italic>in vitro</italic> treatment did not affect murine bone marrow-derived dendritic cells (BM-DCs) cell viability, maturation markers expression, and antigen uptake, these particles significantly downregulated antigen degradation in a size-dependent manner, in association with accumulation in lysosomes but without altering T-cell proliferation (<xref rid="B19" ref-type="bibr">19</xref>). Moreover, NPs and materials traffic to the draining lymph nodes also appear to be size-dependent. Indeed, only small particles (20&#x02013;200&#x02009;nm) are able to drain freely to the lymph nodes (<xref rid="B20" ref-type="bibr">20</xref>).</p><p>In murine BM-DCs, carbon black NPs upregulate the expression of the cell surface molecules CD86, and slightly CD80 and MHC-II molecules, associated with enhancement of allogenic-mixed lymphocyte reaction (<xref rid="B21" ref-type="bibr">21</xref>). TiO<sub>2</sub> NPs were also demonstrated to increase the expression of CD86, CD80, MHC-II, and TNF-&#x003b1; in murine BM-DCs (<xref rid="B22" ref-type="bibr">22</xref>). In murine BM-DCs and in the murine DC line DC 2.4, ultrafine silica NPs decreased cell viability, induced slight phenotypic changes but significantly increased TNF-&#x003b1; production in a size-dependent manner (<xref rid="B23" ref-type="bibr">23</xref>). Interestingly, these effects were correlated with inflammatory response <italic>in vivo</italic> in C57BL/6 mice injected subcutaneously with liquid matrigel containing silica NPs (<xref rid="B23" ref-type="bibr">23</xref>). Winter et al. (<xref rid="B8" ref-type="bibr">8</xref>) studied the effects of aSNPs on murine BM-DCs. Amorphous SNPs were able to affect cell viability through apoptosis and induced partial maturation of BM-DCs as evidenced by enhanced expression of MHC-II and co-stimulatory molecules at the cell surface. Activation of the NLRP3 inflammasome was also reported (<xref rid="B8" ref-type="bibr">8</xref>). Taken together, these observations suggest that certain NP may promote DC maturation and activation, thereby leading to T-lymphocytes activation (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Interaction of nanomaterials and aggregates with DCs</bold>. Nanomaterials and aggregates can be internalized by several receptors present at immature DCs membrane, either by endocytic or phagocytic pathways. Protein aggregates will then be processed by DCs, leading to peptide presentation associated with MHC class II molecules to naive T-lymphocytes. Both nanomaterials coated with a corona or protein aggregates may also be seen as NAMPs and interact with PRR. This interaction can act as a danger signal that induces a signaling cascade leading to the transcription of maturation genes. Mature DC will then be able to express co-stimulation molecules and to produce cytokines and chemokines that will trigger na&#x000ef;ve T-cells activation and polarization. These products can also increase ROS production and initiate the inflammasome activation. CR, complement receptor; DCs, dendritic cells; FcR, immunoglobulin constant fragment receptor; MHC, major histocompatibility complex; NAMP, nanoparticles-associated molecular patterns; PRR, pattern recognition receptors; ROS, reactive oxygen species; Scavenger R, scavenger receptor; TLR, toll-like receptor.</p></caption><graphic xlink:href="fimmu-08-00544-g001"/></fig></sec><sec id="S4"><title>The &#x0201c;Danger Hypothesis&#x0201d; Applied to Exogenous Particles and Nanomaterials</title><p>Danger signals of endogenous or exogenous origin activate DCs and stimulate both the innate and adaptative immune responses. As proposed by Gallo and Gallucci, &#x0201c;classic,&#x0201d; &#x0201c;homeostatic,&#x0201d; and &#x0201c;emerging&#x0201d; danger signals can be distinguished (<xref rid="B24" ref-type="bibr">24</xref>). Classic danger signals are derived from pathogens and released during infections (pathogen-associated molecular patterns) or result from tissue damage, released by necrotic dying cells (damage-associated molecular patterns or &#x0201c;alarmins&#x0201d;) (<xref rid="B25" ref-type="bibr">25</xref>). Homeostatic danger signals are endogenous molecules released during cellular stresses such as hypoxia, acidity, or osmolality perturbations. Chemical sensitizers involved in contact allergy have recently being found to modify the cutaneous microenvironment and/or directly activate DCs resulting in DC phenotype modifications necessary for immune sensitization to these chemicals (<xref rid="B26" ref-type="bibr">26</xref>). Emerging danger signals are newly man-made materials, including nanomaterials, and may either directly activate DCs or indirectly by inducing tissue damage. Thus, it is postulated that immune cells could sense nanomaterials, which could be designated as nanoparticles-associated molecular patterns (Figure <xref ref-type="fig" rid="F1">1</xref>) as described for pathogens (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B24" ref-type="bibr">24</xref>). Sensing of damage signals can be associated with the constitution of inflammasomes, acting as a multiprotein platform to activate caspase-1 and to stimulate the processing of pro-IL-1&#x003b2;. An increase in reactive oxygen species (ROS) production by nanomaterials has been described as an initiating step in the activation of the inflammasome. Interestingly, TiO<sub>2</sub> NPs, associated with the generation of ROS in human DCs, promoted cells maturation and pro-inflammatory cytokine release, whereas CeO<sub>2</sub> NPs, possessing antioxidant properties, triggered human DCs toward an anti-inflammatory profile with IL-10 production (<xref rid="B27" ref-type="bibr">27</xref>). Inflammasome activation can also occur through destabilization and rupture of the lysosome following phagocytosis. Indeed, the lysosome compartment is the most described intracellular site of NP sequestration following endocytosis (<xref rid="B28" ref-type="bibr">28</xref>). Morishige et al. (<xref rid="B29" ref-type="bibr">29</xref>) demonstrated in THP-1 cells that aSNP could induce ROS production, triggered endosomal rupture followed by the activation of NLRP3 inflammasome, and subsequent IL-1-&#x003b2; production (<xref rid="B29" ref-type="bibr">29</xref>). These authors therefore established a direct relationship between oxidative stress and IL-1-&#x003b2; secretion. Nano TiO<sub>2</sub> and nano SiO<sub>2</sub> particles activate the NLRP3 inflammasome in THP-1 cells, correlated with induction of lung inflammation <italic>in vivo</italic> requiring IL-1 receptor expression (<xref rid="B30" ref-type="bibr">30</xref>). Inflammasome activation by nano TiO<sub>2</sub> and nano SiO<sub>2</sub> particles would occur through ATP release and adenosine receptor signaling (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). Moreover, 30&#x02009;nm silica NPs can induce intracellular ATP release and P2X7 receptors purinergic signaling, leading to ROS production, inflammasome activation and stimulating the production of IL-1&#x003b2; and IL-18 in LPS-matured murine BM-DC (<xref rid="B32" ref-type="bibr">32</xref>).</p></sec><sec id="S5"><title>Protein Aggregates, as NPs, Can Drive Immune Responses</title><p>Beyond the strict definition of NPs, we should also consider nanomaterials in a broader sense of the term, since other structures than those derived from nanotechnologies could interact with the immune system (<xref rid="B33" ref-type="bibr">33</xref>). The example of protein aggregates is deeply studied as therapeutic bioproducts (BP) have a propensity to form oligomeric structures that could be assimilated to NPs. It is now well accepted that aggregation of therapeutic proteins is associated with increased potential for immunogenicity in patients, leading to the development of anti-drug antibodies (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>). While the aggregation process is strictly followed and controlled during BP manufacturing process, using orthogonal analysis methods (<xref rid="B36" ref-type="bibr">36</xref>), this is no more the case over transportation, storage, and administration procedures. Several studies have shown that under accelerated stress conditions, proteins can give mixtures of soluble aggregates that are submicron species including oligomers or multimers, mostly detected with dynamic light scattering method, and insoluble aggregates that are above the micrometer range (<xref rid="B37" ref-type="bibr">37</xref>). This was the case for human growth hormone submitted to a stir stress that gave homogenous aggregates around 892&#x02009;nm (<xref rid="B38" ref-type="bibr">38</xref>), or antibody preparations that underwent stir stress (<xref rid="B39" ref-type="bibr">39</xref>), or thermal stress (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Another study showed the appearance of nanosized antibody aggregates upon heat or pH-shift stress that persisted when preparations were diluted in human serum, highlighting the interactions of aggregated proteins with biological fluids (<xref rid="B42" ref-type="bibr">42</xref>). A classification scheme was proposed for antibodies aggregates, based on several biophysical characterizations, in which nanosized particles were present in most of the depicted classes (<xref rid="B43" ref-type="bibr">43</xref>), although they were more represented in the subclass showing &#x0201c;small, partially folded and partially reversible&#x0201d; aggregates (<xref rid="B43" ref-type="bibr">43</xref>). Moreover, protein aggregation can be promoted by the presence of some other nanosized particles, such as glass (<xref rid="B44" ref-type="bibr">44</xref>), tungsten (<xref rid="B45" ref-type="bibr">45</xref>), or leaching from vial stoppers, as hypothesized in the early 2000s, regarding the episode of increased pure red-cell aplasia cases in patients treated with epoietin alpha (<xref rid="B46" ref-type="bibr">46</xref>). Such cases were shown to be mediated by anti-erythropoietin antibodies cross-reacting with the endogenous protein. Several models highlighting protein interactions and aggregation promoted by shedding particles from administration materials have been described (<xref rid="B47" ref-type="bibr">47</xref>&#x02013;<xref rid="B49" ref-type="bibr">49</xref>).</p><p>The effect of protein aggregates on the immune system can be evaluated using <italic>in vivo</italic> models, such as immune-tolerant transgenic mice that can be treated with the human native or aggregated recombinant protein. Immunogenicity is then assessed following IgG titers developed against the administrated component. Such transgenic mice models have been developed for interferons (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>), and a recent paper showed that recombinant interferon beta aggregates induced a break of immune tolerance in transgenic mice, related with the size and structure of the generated aggregates (<xref rid="B52" ref-type="bibr">52</xref>). Using a conventional murine model, another study highlighted that oligomeric antibody aggregates were more immunogenic than larger highly aggregated particles (<xref rid="B41" ref-type="bibr">41</xref>), suggesting that protein aggregation that maintains some native epitopes is more immunogenic. However, the use of <italic>in vitro</italic> models is more convenient to test the effect of aggregated proteins on immune cells. Thus, antibody aggregates have the potential to increase the production of inflammatory cytokines by human PBMC (<xref rid="B53" ref-type="bibr">53</xref>). Testing these aggregates by size showed that nanosized particles induced a lower response than micro-sized particles (<xref rid="B54" ref-type="bibr">54</xref>). The current hypothesis is that aggregates could behave as danger signals and may have mainly an effect on antigen-presenting cells, such as monocytes or DC (Figure <xref ref-type="fig" rid="F1">1</xref>). This hypothesis was objectivized demonstrating that aggregates interaction with PBMC or primary monocytes is partly mediated by toll-like receptors (TLR2 and TLR4), although other receptors such as Fc or complement receptors are also involved (<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B55" ref-type="bibr">55</xref>). DCs are innate immune cells in first line upon therapeutic protein administration, either by intramuscular, intravenous, or subcutaneous administration, as proteins and aggregates rapidly transit in lymph nodes and interact with resident DCs. Also, cutaneous DCs that are present in the point of injection area could be recruited and migrate to peripheral lymph nodes (<xref rid="B56" ref-type="bibr">56</xref>). As therapeutic proteins can be processed by DCs to be presented to T cells, aggregates can interact with pattern recognition receptors, and then induce DCs activation. Indeed, several studies have shown that antibodies or growth hormone (GH) aggregates have the capacity to induce monocyte-derived dendritic cells maturation, evidenced by an increase in phenotypic markers expression, as well as cytokine or chemokine production (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). Both GH and antibodies aggregates could induce the production of IL-6, IL-8, IL-12p40, and CXCL10 whereas CCL2, CCL3, CCL4 production was only seen with GH aggregates (<xref rid="B38" ref-type="bibr">38</xref>). These observations could be extended using the monocytic cell line THP-1, that secreted inflammatory cytokines upon incubation with aggregated intravenous immunoglobulin preparations (<xref rid="B55" ref-type="bibr">55</xref>). Antibody aggregates are able to induce an increase in CD4+&#x02009;T-cell proliferation and to drive T-cell polarization, compared to native counterparts through DCs phenotype modifications (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). Cellular mechanisms by which protein aggregates induce DCs maturation remain to be clarified; however, a few elements are available. It was determined that DCs in contact with aggregates presented a higher number and different class II HLA-associated peptides than native counterparts, suggesting different processing and presentation, and thus neo-epitopes presentation (<xref rid="B57" ref-type="bibr">57</xref>). Although internalization in DCs lysosomal compartment of aggregated antibodies has been evidenced (<xref rid="B58" ref-type="bibr">58</xref>), the exact mechanism, either phagocytosis or macropinocytosis remains to be elucidated. Both certainly take place, depending on the size of the particles (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>).</p></sec><sec id="S6"><title>Conclusion</title><p>Why the immune system should be concerned by nanomaterials? From the literature, it is now clear that exposure to environmental particles can exacerbate or participate to allergic manifestations such as asthma or rhinitis. Diesel exhaust particles and, more recently, products generated through the use of nanotechnology have been shown to have detrimental effects on the respiratory systems, with an exacerbation rate of asthma (<xref rid="B61" ref-type="bibr">61</xref>). Nanomaterials can alter <italic>in vitro</italic> and <italic>in vivo</italic> responses of the immune system to allergens and can also play a role in allergen sensitization. Mimicking danger signals can lead to a direct effect of DCs phenotype (Figure <xref ref-type="fig" rid="F1">1</xref>) having consequences on the adaptive immune system response and recognition of allergens. The recent advances in nanotechnology could also lead to unforeseen adverse health effects mediated by the immune system, nanoimmunosafety, in exposed human subjects (<xref rid="B62" ref-type="bibr">62</xref>).</p></sec><sec id="S7"><title>Author Contributions</title><p>MP organized the manuscript and wrote the general part. AB-V wrote the nanomaterial part of the article. IT wrote the &#x0201c;aggregates&#x0201d; part of the article.</p></sec><sec id="S8"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><sec id="S9"><title>Funding</title><p>This work is supported by Agence nationale de s&#x000e9;curit&#x000e9; sanitaire de l&#x02019;alimentation, de l&#x02019;environnement et du travail (ANSES) grant SILIMMUN.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustafson</surname><given-names>HH</given-names></name><name><surname>Holt-Casper</surname><given-names>D</given-names></name><name><surname>Grainger</surname><given-names>DW</given-names></name><name><surname>Ghandehari</surname><given-names>H</given-names></name></person-group>. <article-title>Nanoparticle uptake: the phagocyte problem</article-title>. <source>Nano Today</source> (<year>2015</year>) <volume>10</volume>(<issue>4</issue>):<fpage>487</fpage>&#x02013;<lpage>510</lpage>.<pub-id pub-id-type="doi">10.1016/j.nantod.2015.06.006</pub-id><pub-id pub-id-type="pmid">26640510</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herd</surname><given-names>HL</given-names></name><name><surname>Bartlett</surname><given-names>KT</given-names></name><name><surname>Gustafson</surname><given-names>JA</given-names></name><name><surname>McGill</surname><given-names>LD</given-names></name><name><surname>Ghandehari</surname><given-names>H</given-names></name></person-group>. <article-title>Macrophage silica nanoparticle response is phenotypically dependent</article-title>. <source>Biomaterials</source> (<year>2015</year>) <volume>53</volume>:<fpage>574</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/j.biomaterials.2015.02.070</pub-id><pub-id pub-id-type="pmid">25890753</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>DA</given-names></name><name><surname>Vanhecke</surname><given-names>D</given-names></name><name><surname>Michen</surname><given-names>B</given-names></name><name><surname>Blank</surname><given-names>F</given-names></name><name><surname>Gehr</surname><given-names>P</given-names></name><name><surname>Petri-Fink</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages</article-title>. <source>Beilstein J Nanotechnol</source> (<year>2014</year>) <volume>5</volume>:<fpage>1625</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.3762/bjnano.5.174</pub-id><pub-id pub-id-type="pmid">25383275</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franca</surname><given-names>A</given-names></name><name><surname>Aggarwal</surname><given-names>P</given-names></name><name><surname>Barsov</surname><given-names>EV</given-names></name><name><surname>Kozlov</surname><given-names>SV</given-names></name><name><surname>Dobrovolskaia</surname><given-names>MA</given-names></name><name><surname>Gonzalez-Fernandez</surname><given-names>A</given-names></name></person-group>. <article-title>Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro</article-title>. <source>Nanomedicine (Lond)</source> (<year>2011</year>) <volume>6</volume>(<issue>7</issue>):<fpage>1175</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.2217/nnm.11.41</pub-id><pub-id pub-id-type="pmid">21675859</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palecanda</surname><given-names>A</given-names></name><name><surname>Paulauskis</surname><given-names>J</given-names></name><name><surname>Al-Mutairi</surname><given-names>E</given-names></name><name><surname>Imrich</surname><given-names>A</given-names></name><name><surname>Qin</surname><given-names>G</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles</article-title>. <source>J Exp Med</source> (<year>1999</year>) <volume>189</volume>(<issue>9</issue>):<fpage>1497</fpage>&#x02013;<lpage>506</lpage>.<pub-id pub-id-type="doi">10.1084/jem.189.9.1497</pub-id><pub-id pub-id-type="pmid">10224290</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orr</surname><given-names>GA</given-names></name><name><surname>Chrisler</surname><given-names>WB</given-names></name><name><surname>Cassens</surname><given-names>KJ</given-names></name><name><surname>Tan</surname><given-names>R</given-names></name><name><surname>Tarasevich</surname><given-names>BJ</given-names></name><name><surname>Markillie</surname><given-names>LM</given-names></name><etal/></person-group>
<article-title>Cellular recognition and trafficking of amorphous silica nanoparticles by macrophage scavenger receptor A</article-title>. <source>Nanotoxicology</source> (<year>2011</year>) <volume>5</volume>(<issue>3</issue>):<fpage>296</fpage>&#x02013;<lpage>311</lpage>.<pub-id pub-id-type="doi">10.3109/17435390.2010.513836</pub-id><pub-id pub-id-type="pmid">20849212</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallhov</surname><given-names>H</given-names></name><name><surname>Gabrielsson</surname><given-names>S</given-names></name><name><surname>Stromme</surname><given-names>M</given-names></name><name><surname>Scheynius</surname><given-names>A</given-names></name><name><surname>Garcia-Bennett</surname><given-names>AE</given-names></name></person-group>. <article-title>Mesoporous silica particles induce size dependent effects on human dendritic cells</article-title>. <source>Nano Lett</source> (<year>2007</year>) <volume>7</volume>(<issue>12</issue>):<fpage>3576</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1021/nl0714785</pub-id><pub-id pub-id-type="pmid">17975942</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>M</given-names></name><name><surname>Beer</surname><given-names>HD</given-names></name><name><surname>Hornung</surname><given-names>V</given-names></name><name><surname>Kramer</surname><given-names>U</given-names></name><name><surname>Schins</surname><given-names>RP</given-names></name><name><surname>Forster</surname><given-names>I</given-names></name></person-group>. <article-title>Activation of the inflammasome by amorphous silica and TiO<sub>2</sub> nanoparticles in murine dendritic cells</article-title>. <source>Nanotoxicology</source> (<year>2011</year>) <volume>5</volume>(<issue>3</issue>):<fpage>326</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.3109/17435390.2010.506957</pub-id><pub-id pub-id-type="pmid">20846021</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>X</given-names></name><name><surname>Leng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name></person-group>. <article-title>The current state of nanoparticle-induced macrophage polarization and reprogramming research</article-title>. <source>Int J Mol Sci</source> (<year>2017</year>) <volume>18</volume>(<issue>2</issue>):<fpage>E336</fpage>.<pub-id pub-id-type="doi">10.3390/ijms18020336</pub-id><pub-id pub-id-type="pmid">28178185</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppstadter</surname><given-names>J</given-names></name><name><surname>Seif</surname><given-names>M</given-names></name><name><surname>Dembek</surname><given-names>A</given-names></name><name><surname>Cavelius</surname><given-names>C</given-names></name><name><surname>Huwer</surname><given-names>H</given-names></name><name><surname>Kraegeloh</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>M2 polarization enhances silica nanoparticle uptake by macrophages</article-title>. <source>Front Pharmacol</source> (<year>2015</year>) <volume>6</volume>:<fpage>55</fpage>.<pub-id pub-id-type="doi">10.3389/fphar.2015.00055</pub-id><pub-id pub-id-type="pmid">25852557</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monopoli</surname><given-names>MP</given-names></name><name><surname>Aberg</surname><given-names>C</given-names></name><name><surname>Salvati</surname><given-names>A</given-names></name><name><surname>Dawson</surname><given-names>KA</given-names></name></person-group>. <article-title>Biomolecular coronas provide the biological identity of nanosized materials</article-title>. <source>Nat Nanotechnol</source> (<year>2012</year>) <volume>7</volume>(<issue>12</issue>):<fpage>779</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1038/nnano.2012.207</pub-id><pub-id pub-id-type="pmid">23212421</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbo</surname><given-names>C</given-names></name><name><surname>Molinaro</surname><given-names>R</given-names></name><name><surname>Parodi</surname><given-names>A</given-names></name><name><surname>Toledano Furman</surname><given-names>NE</given-names></name><name><surname>Salvatore</surname><given-names>F</given-names></name><name><surname>Tasciotti</surname><given-names>E</given-names></name></person-group>. <article-title>The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery</article-title>. <source>Nanomedicine (Lond)</source> (<year>2016</year>) <volume>11</volume>(<issue>1</issue>):<fpage>81</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="doi">10.2217/nnm.15.188</pub-id><pub-id pub-id-type="pmid">26653875</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neagu</surname><given-names>M</given-names></name><name><surname>Piperigkou</surname><given-names>Z</given-names></name><name><surname>Karamanou</surname><given-names>K</given-names></name><name><surname>Engin</surname><given-names>AB</given-names></name><name><surname>Docea</surname><given-names>AO</given-names></name><name><surname>Constantin</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Protein bio-corona: critical issue in immune nanotoxicology</article-title>. <source>Arch Toxicol</source> (<year>2017</year>) <volume>91</volume>(<issue>3</issue>):<fpage>1031</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1007/s00204-016-1797-5</pub-id><pub-id pub-id-type="pmid">27438349</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrera</surname><given-names>C</given-names></name><name><surname>Fadeel</surname><given-names>B</given-names></name></person-group>. <article-title>It takes two to tango: understanding the interactions between engineered nanomaterials and the immune system</article-title>. <source>Eur J Pharm Biopharm</source> (<year>2015</year>) <volume>95</volume>(<issue>Pt A</issue>):<fpage>3</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/j.ejpb.2015.03.007</pub-id><pub-id pub-id-type="pmid">25770769</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapralov</surname><given-names>AA</given-names></name><name><surname>Feng</surname><given-names>WH</given-names></name><name><surname>Amoscato</surname><given-names>AA</given-names></name><name><surname>Yanamala</surname><given-names>N</given-names></name><name><surname>Balasubramanian</surname><given-names>K</given-names></name><name><surname>Winnica</surname><given-names>DE</given-names></name><etal/></person-group>
<article-title>Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration</article-title>. <source>ACS Nano</source> (<year>2012</year>) <volume>6</volume>(<issue>5</issue>):<fpage>4147</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1021/nn300626q</pub-id><pub-id pub-id-type="pmid">22463369</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>ZJ</given-names></name><name><surname>Liang</surname><given-names>M</given-names></name><name><surname>Monteiro</surname><given-names>M</given-names></name><name><surname>Toth</surname><given-names>I</given-names></name><name><surname>Minchin</surname><given-names>RF</given-names></name></person-group>. <article-title>Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation</article-title>. <source>Nat Nanotechnol</source> (<year>2011</year>) <volume>6</volume>(<issue>1</issue>):<fpage>39</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1038/nnano.2010.250</pub-id><pub-id pub-id-type="pmid">21170037</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>ZJ</given-names></name><name><surname>Liang</surname><given-names>M</given-names></name><name><surname>Toth</surname><given-names>I</given-names></name><name><surname>Monteiro</surname><given-names>M</given-names></name><name><surname>Minchin</surname><given-names>RF</given-names></name></person-group>. <article-title>Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses</article-title>. <source>Nanotoxicology</source> (<year>2013</year>) <volume>7</volume>(<issue>3</issue>):<fpage>314</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.3109/17435390.2012.655342</pub-id><pub-id pub-id-type="pmid">22394123</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortimer</surname><given-names>GM</given-names></name><name><surname>Butcher</surname><given-names>NJ</given-names></name><name><surname>Musumeci</surname><given-names>AW</given-names></name><name><surname>Deng</surname><given-names>ZJ</given-names></name><name><surname>Martin</surname><given-names>DJ</given-names></name><name><surname>Minchin</surname><given-names>RF</given-names></name></person-group>. <article-title>Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials</article-title>. <source>ACS Nano</source> (<year>2014</year>) <volume>8</volume>(<issue>4</issue>):<fpage>3357</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1021/nn405830g</pub-id><pub-id pub-id-type="pmid">24617595</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seydoux</surname><given-names>E</given-names></name><name><surname>Rothen-Rutishauser</surname><given-names>B</given-names></name><name><surname>Nita</surname><given-names>IM</given-names></name><name><surname>Balog</surname><given-names>S</given-names></name><name><surname>Gazdhar</surname><given-names>A</given-names></name><name><surname>Stumbles</surname><given-names>PA</given-names></name><etal/></person-group>
<article-title>Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation</article-title>. <source>Int J Nanomedicine</source> (<year>2014</year>) <volume>9</volume>:<fpage>3885</fpage>&#x02013;<lpage>902</lpage>.<pub-id pub-id-type="doi">10.2147/IJN.S64353</pub-id><pub-id pub-id-type="pmid">25152619</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manolova</surname><given-names>V</given-names></name><name><surname>Flace</surname><given-names>A</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Schwarz</surname><given-names>K</given-names></name><name><surname>Saudan</surname><given-names>P</given-names></name><name><surname>Bachmann</surname><given-names>MF</given-names></name></person-group>. <article-title>Nanoparticles target distinct dendritic cell populations according to their size</article-title>. <source>Eur J Immunol</source> (<year>2008</year>) <volume>38</volume>(<issue>5</issue>):<fpage>1404</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1002/eji.200737984</pub-id><pub-id pub-id-type="pmid">18389478</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koike</surname><given-names>E</given-names></name><name><surname>Takano</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Yanagisawa</surname><given-names>R</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name></person-group>. <article-title>Carbon black nanoparticles promote the maturation and function of mouse bone marrow-derived dendritic cells</article-title>. <source>Chemosphere</source> (<year>2008</year>) <volume>73</volume>(<issue>3</issue>):<fpage>371</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.chemosphere.2008.05.054</pub-id><pub-id pub-id-type="pmid">18602660</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>The induction of maturation on dendritic cells by TiO<sub>2</sub> and Fe(3)O(4)@TiO(2) nanoparticles via NF-kappaB signaling pathway</article-title>. <source>Mater Sci Eng C Mater Biol Appl</source> (<year>2014</year>) <volume>39</volume>:<fpage>305</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1016/j.msec.2014.03.005</pub-id><pub-id pub-id-type="pmid">24863229</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>K</given-names></name><name><surname>Lim</surname><given-names>JS</given-names></name></person-group>. <article-title>Induction of functional changes of dendritic cells by silica nanoparticles</article-title>. <source>Immune Netw</source> (<year>2012</year>) <volume>12</volume>(<issue>3</issue>):<fpage>104</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.4110/in.2012.12.3.104</pub-id><pub-id pub-id-type="pmid">22916046</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>PM</given-names></name><name><surname>Gallucci</surname><given-names>S</given-names></name></person-group>. <article-title>The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity</article-title>. <source>Front Immunol</source> (<year>2013</year>) <volume>4</volume>:<fpage>138</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2013.00138</pub-id><pub-id pub-id-type="pmid">23772226</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pradeu</surname><given-names>T</given-names></name><name><surname>Cooper</surname><given-names>EL</given-names></name></person-group>. <article-title>The danger theory: 20 years later</article-title>. <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>:<fpage>287</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2012.00287</pub-id><pub-id pub-id-type="pmid">23060876</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Migdal</surname><given-names>C</given-names></name><name><surname>Botton</surname><given-names>J</given-names></name><name><surname>El Ali</surname><given-names>Z</given-names></name><name><surname>Azoury</surname><given-names>ME</given-names></name><name><surname>Guldemann</surname><given-names>J</given-names></name><name><surname>Gimenez-Arnau</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Reactivity of chemical sensitizers toward amino acids in cellulo plays a role in the activation of the Nrf2-ARE pathway in human monocyte dendritic cells and the THP-1 cell line</article-title>. <source>Toxicol Sci</source> (<year>2013</year>) <volume>133</volume>(<issue>2</issue>):<fpage>259</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1093/toxsci/kft075</pub-id><pub-id pub-id-type="pmid">23535360</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schanen</surname><given-names>BC</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Reilly</surname><given-names>CM</given-names></name><name><surname>Warren</surname><given-names>WL</given-names></name><name><surname>Self</surname><given-names>WT</given-names></name><name><surname>Seal</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Immunomodulation and T helper TH(1)/TH(2) response polarization by CeO(2) and TiO(2) nanoparticles</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>5</issue>):<fpage>e62816</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0062816</pub-id><pub-id pub-id-type="pmid">23667525</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>ST</given-names></name><name><surname>Adiseshaiah</surname><given-names>PP</given-names></name><name><surname>Crist</surname><given-names>RM</given-names></name></person-group>. <article-title>Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity</article-title>. <source>Part Fibre Toxicol</source> (<year>2012</year>) <volume>9</volume>:<fpage>20</fpage>.<pub-id pub-id-type="doi">10.1186/1743-8977-9-20</pub-id><pub-id pub-id-type="pmid">22697169</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morishige</surname><given-names>T</given-names></name><name><surname>Yoshioka</surname><given-names>Y</given-names></name><name><surname>Tanabe</surname><given-names>A</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Tsunoda</surname><given-names>S</given-names></name><name><surname>Tsutsumi</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Titanium dioxide induces different levels of IL-1beta production dependent on its particle characteristics through caspase-1 activation mediated by reactive oxygen species and cathepsin B</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2010</year>) <volume>392</volume>(<issue>2</issue>):<fpage>160</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbrc.2009.12.178</pub-id><pub-id pub-id-type="pmid">20059972</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yazdi</surname><given-names>AS</given-names></name><name><surname>Guarda</surname><given-names>G</given-names></name><name><surname>Riteau</surname><given-names>N</given-names></name><name><surname>Drexler</surname><given-names>SK</given-names></name><name><surname>Tardivel</surname><given-names>A</given-names></name><name><surname>Couillin</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>(<issue>45</issue>):<fpage>19449</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1008155107</pub-id><pub-id pub-id-type="pmid">20974980</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>L</given-names></name><name><surname>Gombault</surname><given-names>A</given-names></name><name><surname>Fanny</surname><given-names>M</given-names></name><name><surname>Villeret</surname><given-names>B</given-names></name><name><surname>Savigny</surname><given-names>F</given-names></name><name><surname>Guillou</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine</article-title>. <source>Cell Death Dis</source> (<year>2015</year>) <volume>6</volume>:<fpage>e1629</fpage>.<pub-id pub-id-type="doi">10.1038/cddis.2014.576</pub-id><pub-id pub-id-type="pmid">25654762</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>K</given-names></name><name><surname>Tsukimoto</surname><given-names>M</given-names></name><name><surname>Tanuma</surname><given-names>S</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Kojima</surname><given-names>S</given-names></name></person-group>. <article-title>Silica nanoparticles activate purinergic signaling via P2X7 receptor in dendritic cells, leading to production of pro-inflammatory cytokines</article-title>. <source>Toxicol In Vitro</source> (<year>2016</year>) <volume>35</volume>:<fpage>202</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/j.tiv.2016.06.003</pub-id><pub-id pub-id-type="pmid">27311643</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilinskaya</surname><given-names>AN</given-names></name><name><surname>Dobrovolskaia</surname><given-names>MA</given-names></name></person-group>. <article-title>Understanding the immunogenicity and antigenicity of nanomaterials: past, present and future</article-title>. <source>Toxicol Appl Pharmacol</source> (<year>2016</year>) <volume>299</volume>:<fpage>70</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.taap.2016.01.005</pub-id><pub-id pub-id-type="pmid">26773813</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratanji</surname><given-names>KD</given-names></name><name><surname>Derrick</surname><given-names>JP</given-names></name><name><surname>Dearman</surname><given-names>RJ</given-names></name><name><surname>Kimber</surname><given-names>I</given-names></name></person-group>. <article-title>Immunogenicity of therapeutic proteins: influence of aggregation</article-title>. <source>J Immunotoxicol</source> (<year>2014</year>) <volume>11</volume>(<issue>2</issue>):<fpage>99</fpage>&#x02013;<lpage>109</lpage>.<pub-id pub-id-type="doi">10.3109/1547691X.2013.821564</pub-id><pub-id pub-id-type="pmid">23919460</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Singh</surname><given-names>SK</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Toler</surname><given-names>MR</given-names></name><name><surname>King</surname><given-names>KR</given-names></name><name><surname>Nema</surname><given-names>S</given-names></name></person-group>. <article-title>Immunogenicity of protein aggregates-concerns and realities</article-title>. <source>Int J Pharm</source> (<year>2012</year>) <volume>431</volume>(<issue>1&#x02013;2</issue>):<fpage>1</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijpharm.2012.04.040</pub-id><pub-id pub-id-type="pmid">22546296</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>den Engelsman</surname><given-names>J</given-names></name><name><surname>Garidel</surname><given-names>P</given-names></name><name><surname>Smulders</surname><given-names>R</given-names></name><name><surname>Koll</surname><given-names>H</given-names></name><name><surname>Smith</surname><given-names>B</given-names></name><name><surname>Bassarab</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Strategies for the assessment of protein aggregates in pharmaceutical biotech product development</article-title>. <source>Pharm Res</source> (<year>2011</year>) <volume>28</volume>(<issue>4</issue>):<fpage>920</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1007/s11095-010-0297-1</pub-id><pub-id pub-id-type="pmid">20972611</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahler</surname><given-names>HC</given-names></name><name><surname>Friess</surname><given-names>W</given-names></name><name><surname>Grauschopf</surname><given-names>U</given-names></name><name><surname>Kiese</surname><given-names>S</given-names></name></person-group>. <article-title>Protein aggregation: pathways, induction factors and analysis</article-title>. <source>J Pharm Sci</source> (<year>2009</year>) <volume>98</volume>(<issue>9</issue>):<fpage>2909</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1002/jps.21566</pub-id><pub-id pub-id-type="pmid">18823031</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallais</surname><given-names>Y</given-names></name><name><surname>Szely</surname><given-names>N</given-names></name><name><surname>Legrand</surname><given-names>FX</given-names></name><name><surname>Leroy</surname><given-names>A</given-names></name><name><surname>Pallardy</surname><given-names>M</given-names></name><name><surname>Turbica</surname><given-names>I</given-names></name></person-group>
<article-title>Effect of growth hormone and IgG aggregates on dendritic cells activation and T-cells polarization</article-title>. <source>Immunol Cell Biol</source> (<year>2016</year>) <volume>95</volume>(<issue>3</issue>):<fpage>306</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1038/icb.2016.100</pub-id><pub-id pub-id-type="pmid">27713394</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahler</surname><given-names>HC</given-names></name><name><surname>Muller</surname><given-names>R</given-names></name><name><surname>Friess</surname><given-names>W</given-names></name><name><surname>Delille</surname><given-names>A</given-names></name><name><surname>Matheus</surname><given-names>S</given-names></name></person-group>. <article-title>Induction and analysis of aggregates in a liquid IgG1-antibody formulation</article-title>. <source>Eur J Pharm Biopharm</source> (<year>2005</year>) <volume>59</volume>(<issue>3</issue>):<fpage>407</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1016/j.ejpb.2004.12.004</pub-id><pub-id pub-id-type="pmid">15760721</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>G</given-names></name><name><surname>Iyer</surname><given-names>V</given-names></name><name><surname>Kosloski</surname><given-names>MP</given-names></name><name><surname>Pisal</surname><given-names>DS</given-names></name><name><surname>Shin</surname><given-names>E</given-names></name><name><surname>Middaugh</surname><given-names>CR</given-names></name><etal/></person-group>
<article-title>Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeutics</article-title>. <source>J Pharm Sci</source> (<year>2010</year>) <volume>99</volume>(<issue>4</issue>):<fpage>1697</fpage>&#x02013;<lpage>706</lpage>.<pub-id pub-id-type="doi">10.1002/jps.21938</pub-id><pub-id pub-id-type="pmid">19798762</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fathallah</surname><given-names>AM</given-names></name><name><surname>Chiang</surname><given-names>M</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Xue</surname><given-names>L</given-names></name><name><surname>Middaugh</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>The effect of small oligomeric protein aggregates on the immunogenicity of intravenous and subcutaneous administered antibodies</article-title>. <source>J Pharm Sci</source> (<year>2015</year>) <volume>104</volume>(<issue>11</issue>):<fpage>3691</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="doi">10.1002/jps.24592</pub-id><pub-id pub-id-type="pmid">26228094</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipe</surname><given-names>V</given-names></name><name><surname>Jiskoot</surname><given-names>W</given-names></name><name><surname>Basmeleh</surname><given-names>AH</given-names></name><name><surname>Halim</surname><given-names>A</given-names></name><name><surname>Schellekens</surname><given-names>H</given-names></name><name><surname>Brinks</surname><given-names>V</given-names></name></person-group>. <article-title>Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice</article-title>. <source>MAbs</source> (<year>2012</year>) <volume>4</volume>(<issue>6</issue>):<fpage>740</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.4161/mabs.22066</pub-id><pub-id pub-id-type="pmid">22951518</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joubert</surname><given-names>MK</given-names></name><name><surname>Luo</surname><given-names>Q</given-names></name><name><surname>Nashed-Samuel</surname><given-names>Y</given-names></name><name><surname>Wypych</surname><given-names>J</given-names></name><name><surname>Narhi</surname><given-names>LO</given-names></name></person-group>. <article-title>Classification and characterization of therapeutic antibody aggregates</article-title>. <source>J Biol Chem</source> (<year>2011</year>) <volume>286</volume>(<issue>28</issue>):<fpage>25118</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M110.160457</pub-id><pub-id pub-id-type="pmid">21454532</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fradkin</surname><given-names>AH</given-names></name><name><surname>Carpenter</surname><given-names>JF</given-names></name><name><surname>Randolph</surname><given-names>TW</given-names></name></person-group>. <article-title>Glass particles as an adjuvant: a model for adverse immunogenicity of therapeutic proteins</article-title>. <source>J Pharm Sci</source> (<year>2011</year>) <volume>100</volume>(<issue>11</issue>):<fpage>4953</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1002/jps.22683</pub-id><pub-id pub-id-type="pmid">21721003</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidl</surname><given-names>A</given-names></name><name><surname>Hainzl</surname><given-names>O</given-names></name><name><surname>Richter</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>R</given-names></name><name><surname>Bohm</surname><given-names>S</given-names></name><name><surname>Deutel</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity</article-title>. <source>Pharm Res</source> (<year>2012</year>) <volume>29</volume>(<issue>6</issue>):<fpage>1454</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1007/s11095-011-0621-4</pub-id><pub-id pub-id-type="pmid">22094831</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casadevall</surname><given-names>N</given-names></name><name><surname>Nataf</surname><given-names>J</given-names></name><name><surname>Viron</surname><given-names>B</given-names></name><name><surname>Kolta</surname><given-names>A</given-names></name><name><surname>Kiladjian</surname><given-names>JJ</given-names></name><name><surname>Martin-Dupont</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin</article-title>. <source>N Engl J Med</source> (<year>2002</year>) <volume>346</volume>(<issue>7</issue>):<fpage>469</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa011931</pub-id><pub-id pub-id-type="pmid">11844847</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bee</surname><given-names>JS</given-names></name><name><surname>Chiu</surname><given-names>D</given-names></name><name><surname>Sawicki</surname><given-names>S</given-names></name><name><surname>Stevenson</surname><given-names>JL</given-names></name><name><surname>Chatterjee</surname><given-names>K</given-names></name><name><surname>Freund</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Monoclonal antibody interactions with micro- and nanoparticles: adsorption, aggregation, and accelerated stress studies</article-title>. <source>J Pharm Sci</source> (<year>2009</year>) <volume>98</volume>(<issue>9</issue>):<fpage>3218</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1002/jps.21768</pub-id><pub-id pub-id-type="pmid">19492408</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Randolph</surname><given-names>TW</given-names></name><name><surname>Carpenter</surname><given-names>JF</given-names></name></person-group>. <article-title>Particles shed from syringe filters and their effects on agitation-induced protein aggregation</article-title>. <source>J Pharm Sci</source> (<year>2012</year>) <volume>101</volume>(<issue>8</issue>):<fpage>2952</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1002/jps.23225</pub-id><pub-id pub-id-type="pmid">22674153</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krayukhina</surname><given-names>E</given-names></name><name><surname>Tsumoto</surname><given-names>K</given-names></name><name><surname>Uchiyama</surname><given-names>S</given-names></name><name><surname>Fukui</surname><given-names>K</given-names></name></person-group>. <article-title>Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins</article-title>. <source>J Pharm Sci</source> (<year>2015</year>) <volume>104</volume>(<issue>2</issue>):<fpage>527</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1002/jps.24184</pub-id><pub-id pub-id-type="pmid">25256796</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermeling</surname><given-names>S</given-names></name><name><surname>Schellekens</surname><given-names>H</given-names></name><name><surname>Maas</surname><given-names>C</given-names></name><name><surname>Gebbink</surname><given-names>MF</given-names></name><name><surname>Crommelin</surname><given-names>DJ</given-names></name><name><surname>Jiskoot</surname><given-names>W</given-names></name></person-group>. <article-title>Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation</article-title>. <source>J Pharm Sci</source> (<year>2006</year>) <volume>95</volume>(<issue>5</issue>):<fpage>1084</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1002/jps.20599</pub-id><pub-id pub-id-type="pmid">16552750</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Beers</surname><given-names>MM</given-names></name><name><surname>Sauerborn</surname><given-names>M</given-names></name><name><surname>Gilli</surname><given-names>F</given-names></name><name><surname>Brinks</surname><given-names>V</given-names></name><name><surname>Schellekens</surname><given-names>H</given-names></name><name><surname>Jiskoot</surname><given-names>W</given-names></name></person-group>. <article-title>Aggregated recombinant human interferon beta induces antibodies but no memory in immune-tolerant transgenic mice</article-title>. <source>Pharm Res</source> (<year>2010</year>) <volume>27</volume>(<issue>9</issue>):<fpage>1812</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1007/s11095-010-0172-0</pub-id><pub-id pub-id-type="pmid">20499141</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdolvahab</surname><given-names>MH</given-names></name><name><surname>Fazeli</surname><given-names>A</given-names></name><name><surname>Halim</surname><given-names>A</given-names></name><name><surname>Sediq</surname><given-names>AS</given-names></name><name><surname>Fazeli</surname><given-names>MR</given-names></name><name><surname>Schellekens</surname><given-names>H</given-names></name></person-group>. <article-title>Immunogenicity of recombinant human interferon beta-1b in immune-tolerant transgenic mice corresponds with the biophysical characteristics of aggregates</article-title>. <source>J Interferon Cytokine Res</source> (<year>2016</year>) <volume>36</volume>(<issue>4</issue>):<fpage>247</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1089/jir.2015.0108</pub-id><pub-id pub-id-type="pmid">26835734</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joubert</surname><given-names>MK</given-names></name><name><surname>Hokom</surname><given-names>M</given-names></name><name><surname>Eakin</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Deshpande</surname><given-names>M</given-names></name><name><surname>Baker</surname><given-names>MP</given-names></name><etal/></person-group>
<article-title>Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses</article-title>. <source>J Biol Chem</source> (<year>2012</year>) <volume>287</volume>(<issue>30</issue>):<fpage>25266</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M111.330902</pub-id><pub-id pub-id-type="pmid">22584577</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telikepalli</surname><given-names>S</given-names></name><name><surname>Shinogle</surname><given-names>HE</given-names></name><name><surname>Thapa</surname><given-names>PS</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Deshpande</surname><given-names>M</given-names></name><name><surname>Jawa</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting</article-title>. <source>J Pharm Sci</source> (<year>2015</year>) <volume>104</volume>(<issue>5</issue>):<fpage>1575</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1002/jps.24379</pub-id><pub-id pub-id-type="pmid">25753756</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moussa</surname><given-names>EM</given-names></name><name><surname>Kotarek</surname><given-names>J</given-names></name><name><surname>Blum</surname><given-names>JS</given-names></name><name><surname>Marszal</surname><given-names>E</given-names></name><name><surname>Topp</surname><given-names>EM</given-names></name></person-group>. <article-title>Physical characterization and innate immunogenicity of aggregated intravenous immunoglobulin (IGIV) in an in vitro cell-based model</article-title>. <source>Pharm Res</source> (<year>2016</year>) <volume>33</volume>(<issue>7</issue>):<fpage>1736</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1007/s11095-016-1914-4</pub-id><pub-id pub-id-type="pmid">27037576</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fathallah</surname><given-names>AM</given-names></name><name><surname>Bankert</surname><given-names>RB</given-names></name><name><surname>Balu-Iyer</surname><given-names>SV</given-names></name></person-group>
<article-title>Immunogenicity of subcutaneously administered therapeutic proteins&#x02014;a mechanistic perspective</article-title>. <source>AAPS J</source> (<year>2013</year>) <volume>15</volume>(<issue>4</issue>):<fpage>897</fpage>&#x02013;<lpage>900</lpage>.<pub-id pub-id-type="doi">10.1208/s12248-013-9510-6</pub-id><pub-id pub-id-type="pmid">23856740</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rombach-Riegraf</surname><given-names>V</given-names></name><name><surname>Karle</surname><given-names>AC</given-names></name><name><surname>Wolf</surname><given-names>B</given-names></name><name><surname>Sorde</surname><given-names>L</given-names></name><name><surname>Koepke</surname><given-names>S</given-names></name><name><surname>Gottlieb</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Aggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitro</article-title>. <source>PLoS One</source> (<year>2014</year>) <volume>9</volume>(<issue>1</issue>):<fpage>e86322</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0086322</pub-id><pub-id pub-id-type="pmid">24466023</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi</surname><given-names>M</given-names></name><name><surname>Bryson</surname><given-names>CJ</given-names></name><name><surname>Cloake</surname><given-names>EA</given-names></name><name><surname>Welch</surname><given-names>K</given-names></name><name><surname>Filipe</surname><given-names>V</given-names></name><name><surname>Romeijn</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics</article-title>. <source>Pharm Res</source> (<year>2015</year>) <volume>32</volume>(<issue>4</issue>):<fpage>1383</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1007/s11095-014-1541-x</pub-id><pub-id pub-id-type="pmid">25319104</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>L</given-names></name><name><surname>Nienhaus</surname><given-names>K</given-names></name><name><surname>Nienhaus</surname><given-names>GU</given-names></name></person-group>. <article-title>Engineered nanoparticles interacting with cells: size matters</article-title>. <source>J Nanobiotechnology</source> (<year>2014</year>) <volume>12</volume>:<fpage>5</fpage>.<pub-id pub-id-type="doi">10.1186/1477-3155-12-5</pub-id><pub-id pub-id-type="pmid">24491160</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couceiro</surname><given-names>JR</given-names></name><name><surname>Gallardo</surname><given-names>R</given-names></name><name><surname>De Smet</surname><given-names>F</given-names></name><name><surname>De Baets</surname><given-names>G</given-names></name><name><surname>Baatsen</surname><given-names>P</given-names></name><name><surname>Annaert</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Sequence-dependent internalization of aggregating peptides</article-title>. <source>J Biol Chem</source> (<year>2015</year>) <volume>290</volume>(<issue>1</issue>):<fpage>242</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M114.586636</pub-id><pub-id pub-id-type="pmid">25391649</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Georas</surname><given-names>S</given-names></name><name><surname>Alexis</surname><given-names>N</given-names></name><name><surname>Fritz</surname><given-names>P</given-names></name><name><surname>Xia</surname><given-names>T</given-names></name><name><surname>Williams</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>A work group report on ultrafine particles (American Academy of Allergy, Asthma &#x00026; Immunology): why ambient ultrafine and engineered nanoparticles should receive special attention for possible adverse health outcomes in human subjects</article-title>. <source>J Allergy Clin Immunol</source> (<year>2016</year>) <volume>138</volume>(<issue>2</issue>):<fpage>386</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaci.2016.02.023</pub-id><pub-id pub-id-type="pmid">27130856</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Italiani</surname><given-names>P</given-names></name><name><surname>Casals</surname><given-names>E</given-names></name><name><surname>Valkenborg</surname><given-names>D</given-names></name><name><surname>Mertens</surname><given-names>I</given-names></name><name><surname>Baggerman</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Assessing the immunosafety of engineered nanoparticles with a novel in vitro model based on human primary monocytes</article-title>. <source>ACS Appl Mater Interfaces</source> (<year>2016</year>) <volume>8</volume>(<issue>42</issue>):<fpage>28437</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1021/acsami.6b06278</pub-id></mixed-citation></ref></ref-list></back></article>